THE VOGEL GROUP

Lobbying for HDT BIO CORP · Medical Research Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Washington · House · Senate · $49,500.00 income · posted Oct 20, 2025

Lobbying activity 3

Health Issues

Issues related to emerging biological threats and drug development

Medical/Disease Research/Clinical Labs

Issues related to emerging biological threats and drug development

Science/Technology

Issues related to emerging biological threats and drug development

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.